p53-related pathways and the molecular pathogenesis of melanoma
- 1 April 2003
- journal article
- review article
- Published by Wolters Kluwer Health in European Journal Of Cancer Prevention
- Vol. 12 (2), 93-100
- https://doi.org/10.1097/00008469-200304000-00002
Abstract
Cutaneous malignant melanoma (CMM) is a life-threatening cancer that can have a poor prognosis with high metastatic potential. Its incidence is rapidly increasing worldwide. Its molecular alterations involve multiple pathways, including those related to p53. Since 1981, more than 380 papers containing the terms ‘p53 and melanoma’ as key words in the Abstract have been published in the literature. However, in spite of these extensive investigations, a review of p53 and associated genes in CMM is still lacking. To remedy this issue, this review seeks to provide a brief overview of p53 and discuss the genes targeted along its related pathways.Keywords
This publication has 81 references indexed in Scilit:
- Loss of p14ARF expression in melanomaArchives of Dermatological Research, 2001
- Exonucleolytic proofreading by p53 proteinEuropean Journal of Biochemistry, 2001
- Physical and Functional Interaction between p53 and the Werner's Syndrome ProteinJournal of Biological Chemistry, 1999
- Genes involved in melanomaMelanoma Research, 1999
- Frequent mutations of the p53 gene in cutaneous melanoma of the nodular typeInternational Journal of Cancer, 1998
- Cooperative effects of INK4a and ras in melanoma susceptibility in vivoGenes & Development, 1997
- TP53 allele loss, mutations and expression in malignant melanomaBritish Journal of Cancer, 1994
- Mutation and expression of the p53 gene in human malignant melanomaMelanoma Research, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992